NCT06261554 is a NA clinical trial of Dietary Supplement: Low dose OIT in Food Allergy, sponsored by Medical University of Warsaw.

Who is sponsoring NCT06261554?

NCT06261554 is sponsored by Medical University of Warsaw.

What drugs are being tested in NCT06261554?

Interventions in NCT06261554: Dietary Supplement: Low dose OIT.

What condition does NCT06261554 study?

NCT06261554 studies Food Allergy.

Is NCT06261554 still recruiting?

NCT06261554 is currently recruiting now. Last updated 20 May 2024.

Last reviewed 2024-05-20 · How we verify

NCT06261554

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

Recruiting now NA Last updated 20 May 2024

What this trial tests

NA trial testing Dietary Supplement: Low dose OIT in Food Allergy in 39 participants. Currently enrolling.

Timeline

14 March 2024

Primary endpoint
1 March 2026

1 March 2027

Quick facts

Lead sponsor	Medical University of Warsaw
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	39
Start date	14 March 2024
Primary completion	1 March 2026
Estimated completion	1 March 2027
Sites	1 location across Poland

Drugs / interventions tested

Dietary Supplement: Low dose OIT

Conditions studied

Food Allergy — all drugs for Food Allergy →

Sponsor

Medical University of Warsaw

Who can join

Adults 3 to 17, any sex, with Food Allergy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is a randomized, single-center, controlled trial to evaluate the effectiveness of oral immunotherapy with low-dose sesame protein compared with standard treatment (elimination diet) in patients with sesame allergy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy and safety of low-dose sesame oral immunotherapy in paediatric patients: a protocol for a single-centre, randomised controlled trial.
Zielinska J, Zagórska W, Krupa-Łaska A, Łyżwa K, et al · · 2024 · cited 7× · PMID 39134434 · DOI 10.1136/bmjopen-2024-085811

Verify or expand the search:

Other recruiting trials for Food Allergy

Currently open trials in the same condition.

NCT07210320 — PK/PD Study of IN-001 Sublingual Spray in Healthy Adults · Phase 1 · recruiting
NCT06943534 — Omalizumab Weight-Based Dosing Efficacy Trial · Phase 2 · recruiting
NCT06872996 — Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results · NA · recruiting
NCT06529913 — Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases · NA · recruiting
NCT06558526 — Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients · NA · recruiting

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06261554 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 20 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06261554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing